These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32572960)

  • 21. Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, suppresses hepatic gluconeogenesis through 5'-AMP-activated protein kinase.
    Collins QF; Liu HY; Pi J; Liu Z; Quon MJ; Cao W
    J Biol Chem; 2007 Oct; 282(41):30143-9. PubMed ID: 17724029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Epigallo-Catechin-3-Gallate on Lipid Metabolism Related Gene Expression and Yolk Fatty Acid Profiles of Laying Hens Exposed to Vanadium.
    Qiu LY; Wang JP; Pietro C; Zhang KY; Ding XM; Bai SP; Zeng QF; Peng HW
    Biol Trace Elem Res; 2019 Aug; 190(2):501-508. PubMed ID: 30406489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Green tea (-)-epigallocatechin-3-gallate reduces body weight with regulation of multiple genes expression in adipose tissue of diet-induced obese mice.
    Lee MS; Kim CT; Kim Y
    Ann Nutr Metab; 2009; 54(2):151-7. PubMed ID: 19390166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diosgenin ameliorates palmitic acid-induced lipid accumulation via AMPK/ACC/CPT-1A and SREBP-1c/FAS signaling pathways in LO2 cells.
    Fang K; Wu F; Chen G; Dong H; Li J; Zhao Y; Xu L; Zou X; Lu F
    BMC Complement Altern Med; 2019 Sep; 19(1):255. PubMed ID: 31519174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adropin inhibited tilapia hepatic glucose output and triglyceride accumulation via AMPK activation.
    Zhang C; Zhang Q; Huang Z; Jiang Q
    J Endocrinol; 2020 Aug; 246(2):109-122. PubMed ID: 32485680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low abundance of mitofusin 2 in dairy cows with moderate fatty liver is associated with alterations in hepatic lipid metabolism.
    Dong J; Loor JJ; Zuo R; Chen X; Liang Y; Wang Y; Shu X; Sun X; Jia H; Liu G; Wang Z; Li X; Li X
    J Dairy Sci; 2019 Aug; 102(8):7536-7547. PubMed ID: 31178189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of the new thiazolidine derivative LPSF/GQ-02 on hepatic lipid metabolism pathways in non-alcoholic fatty liver disease (NAFLD).
    Araújo S; Soares E Silva A; Gomes F; Ribeiro E; Oliveira W; Oliveira A; Lima I; Lima MDC; Pitta I; Peixoto C
    Eur J Pharmacol; 2016 Oct; 788():306-314. PubMed ID: 27349145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morin reduces inflammatory responses and alleviates lipid accumulation in hepatocytes.
    Wu L; Wang Y; Chi G; Shen B; Tian Y; Li Z; Han L; Zhang Q; Feng H
    J Cell Physiol; 2019 Nov; 234(11):19785-19798. PubMed ID: 30937936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isoquercitrin activates the AMP-activated protein kinase (AMPK) signal pathway in rat H4IIE cells.
    Zhou J; Yoshitomi H; Liu T; Zhou B; Sun W; Qin L; Guo X; Huang L; Wu L; Gao M
    BMC Complement Altern Med; 2014 Feb; 14():42. PubMed ID: 24490657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigallocatechin-3-gallate inhibits angiotensin II-induced C-reactive protein generation through interfering with the AT
    Zhao J; Liu J; Pang X; Zhang X; Wang S; Wu D
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Nov; 389(11):1225-1234. PubMed ID: 27492718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tomatidine Reduces Palmitate-Induced Lipid Accumulation by Activating AMPK via Vitamin D Receptor-Mediated Signaling in Human HepG2 Hepatocytes.
    Kusu H; Yoshida H; Kudo M; Okuyama M; Harada N; Tsuji-Naito K; Akagawa M
    Mol Nutr Food Res; 2019 Nov; 63(22):e1801377. PubMed ID: 31454158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dietary (-)-Epigallocatechin-3-gallate Supplementation Counteracts Aging-Associated Skeletal Muscle Insulin Resistance and Fatty Liver in Senescence-Accelerated Mouse.
    Liu HW; Chan YC; Wang MF; Wei CC; Chang SJ
    J Agric Food Chem; 2015 Sep; 63(38):8407-17. PubMed ID: 26152236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin D attenuates high fat diet-induced hepatic steatosis in rats by modulating lipid metabolism.
    Yin Y; Yu Z; Xia M; Luo X; Lu X; Ling W
    Eur J Clin Invest; 2012 Nov; 42(11):1189-96. PubMed ID: 22958216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of
    Mun J; Park J; Yoon HG; You Y; Choi KC; Lee YH; Kim K; Lee J; Kim OK; Jun W
    J Med Food; 2019 Dec; 22(12):1262-1270. PubMed ID: 31834842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The herbal composition GGEx18 from Laminaria japonica, Rheum palmatum, and Ephedra sinica reduces obesity via skeletal muscle AMPK and PPARα.
    Shin SS; Park D; Lee HY; Hong Y; Choi J; Oh J; Lee H; Lee HR; Kim MR; Shen ZB; Cui HH; Yoon M
    Pharm Biol; 2012 Apr; 50(4):506-15. PubMed ID: 22129093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BHBA regulates the expressions of lipid synthesis and oxidation genes in sheep hepatocytes through the AMPK pathway.
    Zou D; Liu R; Shi S; Du J; Tian M; Wang X; Hou M; Duan Z; Ma Y
    Res Vet Sci; 2021 Nov; 140():153-163. PubMed ID: 34481206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Free Fatty Acids Increase Intracellular Lipid Accumulation and Oxidative Stress by Modulating PPARα and SREBP-1c in L-02 Cells.
    Qin S; Yin J; Huang K
    Lipids; 2016 Jul; 51(7):797-805. PubMed ID: 27270405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PPARα, PPARγ and SREBP-1 pathways mediated waterborne iron (Fe)-induced reduction in hepatic lipid deposition of javelin goby Synechogobius hasta.
    Chen GH; Luo Z; Chen F; Shi X; Song YF; You WJ; Liu X
    Comp Biochem Physiol C Toxicol Pharmacol; 2017 Jul; 197():8-18. PubMed ID: 28411055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigallocatechin gallate suppresses hepatic cholesterol synthesis by targeting SREBP-2 through SIRT1/FOXO1 signaling pathway.
    Li Y; Wu S
    Mol Cell Biochem; 2018 Nov; 448(1-2):175-185. PubMed ID: 29446047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Farnesol, an isoprenoid, improves metabolic abnormalities in mice via both PPARα-dependent and -independent pathways.
    Goto T; Kim YI; Funakoshi K; Teraminami A; Uemura T; Hirai S; Lee JY; Makishima M; Nakata R; Inoue H; Senju H; Matsunaga M; Horio F; Takahashi N; Kawada T
    Am J Physiol Endocrinol Metab; 2011 Nov; 301(5):E1022-32. PubMed ID: 21862726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.